SCHEMBL7490972

SCHEMBL7490972

COc1cccc(CC2CCN(Cc3ccccc3)C2c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 6/20 0.49
SIGMAR1 Q99720 5/20 0.44
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
HTR1A P08908 4/20 0.41
TMEM97 Q5BJF2 3/20 0.41
HTR2B P41595 3/20 0.41
DRD4 P21917 2/20 0.41
HTR2C P28335 2/20 0.41
SLC6A3 Q01959 2/20 0.41
SLC6A4 P31645 2/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
SLC6A2 P23975 1/20 0.41
OPRK1 P41145 1/20 0.41
HTR5A P47898 1/20 0.41
CHRM2 P08172 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546572 0.89 PTGIR (0.52) PTGIRRXRARXRB
SCHEMBL8546568 0.87 PTGIR (0.51) PTGIRRXRARXRB
SCHEMBL7487355 0.87 PTGIR (0.60) PTGIRALDH1A1HPGDHSD17B10KDM4E
SCHEMBL8065255 0.80 PTGIR (0.71) PTGIRPDE4APDE4BPDE4CPDE4D
SCHEMBL7485700 0.80 PTGIR (0.69) PTGIRSIGMAR1HTR1AHTR2BALDH1A1
SCHEMBL7490750 0.77 PTGIR (0.59) PTGIRALDH1A1HPGDHSD17B10KDM4E
SCHEMBL27407593 0.75 PTGIR (0.47) PTGIRRXRARXRBLMNAKDM4E
SCHEMBL8056752 0.75 PTGIR (0.51) PTGIRHTR1ASLC6A4RXRARXRB
SCHEMBL27579519 0.74 PTGIR (0.50) PTGIRHTR1ASLC6A4RXRARXRB
SCHEMBL18409632 0.74 SIGMAR1 (0.62) SIGMAR1HTR1AHTR2BDRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0781310-B1 MONO-N-ALKYL-QUINACRIDONE PIGMENTS CIBA GEIGY AG (CH) 1998-10-21 EP disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
US-5725651-A Mono-N-alkyl-quinacridone pigments CIBA SPECIALTY CHEMICALS CORPORATION (US) 1998-03-10 US disclosed
EP-0781310-A1 MONO-N-ALKYL-QUINACRIDONE PIGMENTS Ciba SC Holding AG (CH) 1997-07-02 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed
WO-1996008536-A1 MONO-N-ALKYL-QUINACRIDONE PIGMENTS CIBA SPECIALTY CHEMICAL HOLDING INC. (CH) 1996-03-21 WO disclosed